Rohden Fabíola
Departamento de Antropologia, Instituto de Filosofia e Ciências Humanas, Universidade Federal do Rio Grande do Sul, Porto Alegre, RS, Brazil.
Cien Saude Colet. 2012 Oct;17(10):2645-54. doi: 10.1590/s1413-81232012001000014.
The scope of this article is to reflect upon the medicalization of male sexuality based on the counterpoint between two distinct historical processes. The first of these is the major trend towards intervention in male sexuality which occurred in the early twentieth century in Brazil as a result of syphilis and the broader campaign against venereal disease. The second concerns the medicalization of sexuality through the focus on erectile dysfunction and the creation of a new pharmacology of sex which has become inevitable with the transition to the twenty-first century. This contrast enables us to see some important differences. The study highlights the new emphasis on the notion of sexual health based on individual improvement and use of medications. It also demonstrates that the promotion of male interest in sexual performance serves as a gateway to approach the treatment of male health.
本文的范围是基于两个不同历史进程之间的对比,来反思男性性行为的医学化。其中第一个进程是20世纪初在巴西因梅毒以及更广泛的性病防治运动而出现的对男性性行为进行干预的主要趋势。第二个进程涉及通过关注勃起功能障碍以及创造一种新的性药理学来实现性行为的医学化,这在向21世纪过渡的过程中已变得不可避免。这种对比使我们能够看到一些重要的差异。该研究强调了基于个体改善和药物使用对性健康概念的新重视。它还表明,促进男性对性表现的兴趣成为了接近男性健康治疗的一个途径。